Insider trades
Kevin Koch, CEO of Edgewise Therapeutics EWTX, has filed 0 purchases and 7 sales on the open market. The latest trade was on 25/08/12.
Kevin Koch
President and CEO
- Company
- Edgewise Therapeutics EWTX
- First filing
- 23/05/03
- Trades
- 26 trades
- Buys / sales
- 0 / 7
- 12-month net buying
- No record
- Last trade
- 25/08/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/08/12 | 25/08/14 | 7,972 sh | $13.39 | $106,745.08 | −20.7% | |
| Open-market sale | 25/05/02 | 25/05/07 | 4,276 sh | $16.45 | $70,340.2 | −17.2% | |
| Open-market sale10b5-1 plan | 25/03/07 | 25/03/11 | 100 sh | $30.00 | $3,000 | −0.7% | |
EWTX | Open-market sale10b5-1 plan | 25/02/05–25/02/06 | 25/02/07 | 9,536 sh2 trades | $30.13avg. | $287,356.08 | −39.7% |
| Open-market sale | 24/05/02 | 24/05/03 | 3,152 sh | $18.91 | $59,604.32 | −17.9% | |
| Open-market sale | 23/05/02 | 23/05/03 | 3,203 sh | $8.90 | $28,506.7 | −30.8% |